Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Clinical trial NCT05667064 · COMPLETED

Trial details

NCT number: NCT05667064
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Unresectable Hepatocellular Carcinoma

Start date: 2023-05-09
Primary completion: 2025-07-21
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.